Showing results (281-290 of 426) with videos related to
Sort By:
Pageof 43
Expert Review of Gastroenterology & Hepatology|October 22, 2024
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinomaBernardo Stefanini, Giulia F Manfredi, Antonio D'Alessio, et al.Journal of Hepatology|February 28, 2026
Efficacy of liver transplantation after response to atezolizumab-bevacizumab downstaging of intermediate and advanced hepatocellular carcinoma (ImmunoXXL)Sherrie Bhoori, Licia Rivoltini, David J Pinato, et al.European Radiology|July 13, 2023
Consensus report from the 10th global forum for liver magnetic resonance imaging: multidisciplinary team discussionBachir Taouli, Ahmed Ba-Ssalamah, Julius Chapiro, et al.Alimentary Pharmacology & Therapeutics|October 17, 2017
The albumin-bilirubin grade uncovers the prognostic relationship between hepatic reserve and immune dysfunction in HIV-associated hepatocellular carcinomaD J Pinato, R Sharma, C Citti, et al.Journal for Immunotherapy of Cancer|October 1, 2021
Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapyDavid J Pinato, Sam M Murray, Alejandro Forner, et al.Journal of Hepatology|February 25, 2021
Activation and transcriptional profile of monocytes and CD8+ T cells are altered in checkpoint inhibitor-related hepatitisCathrin L C Gudd, Lewis Au, Evangelos Triantafyllou, et al.The American Journal of Gastroenterology|February 12, 2026
Antibiotic Use Linked to Worse Outcomes in Gastrointestinal and Liver Cancer Patients on Immune Checkpoint Inhibitors: A Meta-AnalysisMohammad Saeid Rezaee-Zavareh, Hamidreza Karimi-Sari, Peyvand Parhizkar Roudsari, et al.Journal of the National Cancer Institute|July 31, 2024
Immune and gene-expression profiling in estrogen receptor low and negative early breast cancerDavide Massa, Claudio Vernieri, Lorenzo Nicolè, et al.Journal for Immunotherapy of Cancer|July 8, 2021
Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximabJames L Alexander, Hajir Ibraheim, Bhavisha Sheth, et al.The Clinical Journal of Pain|February 6, 2015
Italian Oncological Pain Survey (IOPS): a multicentre Italian study of breakthrough pain performed in different settingsSebastiano Mercadante, Marzia Lazzari, Carlo Reale, et al.Pageof 43